Management of Treatment-Resistant Depression

Rationale for Treatment Modification

The American Academy of Family Physicians recommends modifying treatment if there is inadequate response within 6 to 8 weeks of initiation or dose adjustment 3
The maximum recommended dose of sertraline is 200 mg daily, but continuing to increase the dose beyond 150 mg is unlikely to provide additional benefit 1, 2

The American Academy of Family Physicians suggests switching to a different antidepressant, such as bupropion SR, venlafaxine XR, or mirtazapine, as reasonable alternatives 1, 2, 4
No single antidepressant has proven superior to others in efficacy when switching, so selection should be based on side effect profile and patient-specific factors 3
Bupropion augmentation is supported by evidence showing efficacy in treatment-refractory depression when combined with SSRIs, although the STAR*D trial found no significant difference between augmenting with bupropion versus buspirone 5

The American Academy of Family Physicians recommends confirming adequate trial duration, ensuring the patient has been on sertraline 150 mg for at least 4-8 weeks, as full therapeutic trials require this duration 1, 2
Assessing adherence and evaluating severity and specific symptoms, such as low energy/apathy or anxiety/insomnia, can inform treatment decisions 6
Monitoring closely for suicidal ideation, agitation, or unusual behavioral changes is crucial after treatment modification 3

The American College of Physicians recommends avoiding polypharmacy without clear rationale, and switching may be preferable if there has been minimal or no response to sertraline 3
Tapering sertraline appropriately over 10-14 days can limit withdrawal symptoms, particularly given sertraline's association with discontinuation syndrome 1, 7, 8
Considering combination with psychotherapy, such as cognitive behavioral therapy, may improve outcomes 9
Planning for adequate treatment duration, continuing treatment for 4-9 months for first episode, or longer for recurrent depression, is essential 3, 4